Qingyang Shi

1.9k total citations · 1 hit paper
35 papers, 812 citations indexed

About

Qingyang Shi is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Qingyang Shi has authored 35 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in Qingyang Shi's work include Diabetes Treatment and Management (9 papers), Per- and polyfluoroalkyl substances research (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Qingyang Shi is often cited by papers focused on Diabetes Treatment and Management (9 papers), Per- and polyfluoroalkyl substances research (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Qingyang Shi collaborates with scholars based in China, United States and United Kingdom. Qingyang Shi's co-authors include Sheyu Li, Jay Gan, Yanjiao Shen, X.C. Jiao, Birong Dong, Qiukui Hao, Jin Huang, Kailei Nong, Jirong Yue and Marla Beauchamp and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and Annals of Internal Medicine.

In The Last Decade

Qingyang Shi

33 papers receiving 803 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exercise for sarcopenia in older people: A systematic review and network meta‐analysis

2023 211 citations Yanjiao Shen, Qingyang Shi et al. Journal of Cachexia Sarcopenia and Muscle profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingyang Shi China	15	248	201	138	135	106	35	812
Yu‐Mi Lee South Korea	20	210 0.8×	66 0.3×	435 3.2×	52 0.4×	187 1.8×	61	1.3k
Yumeng Shi China	15	71 0.3×	121 0.6×	396 2.9×	92 0.7×	66 0.6×	72	1.0k
Mingyu Zhang China	17	176 0.7×	64 0.3×	254 1.8×	95 0.7×	292 2.8×	109	1.1k
Valentina Guercio Italy	13	179 0.7×	38 0.2×	341 2.5×	111 0.8×	86 0.8×	18	1.1k
Pengfei Zhu China	15	85 0.3×	65 0.3×	580 4.2×	36 0.3×	85 0.8×	39	1.0k
Kirsten T. Eriksen Denmark	17	41 0.2×	126 0.6×	577 4.2×	419 3.1×	129 1.2×	29	1.1k
Hossam M. Draz Saudi Arabia	16	125 0.5×	73 0.4×	211 1.5×	14 0.1×	168 1.6×	32	817
Naila Khalil United States	16	59 0.2×	87 0.4×	408 3.0×	240 1.8×	52 0.5×	30	806
Shengen Liao China	17	87 0.4×	46 0.2×	115 0.8×	36 0.3×	74 0.7×	67	725
Yanqiu Ou China	23	72 0.3×	49 0.2×	370 2.7×	180 1.3×	302 2.8×	95	1.4k

Countries citing papers authored by Qingyang Shi

Since Specialization

Citations

This map shows the geographic impact of Qingyang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyang Shi more than expected).

Fields of papers citing papers by Qingyang Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyang Shi. The network helps show where Qingyang Shi may publish in the future.

Co-authorship network of co-authors of Qingyang Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyang Shi. A scholar is included among the top collaborators of Qingyang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyang Shi. Qingyang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zou, Xinyu, Qingyang Shi, Si Wang, et al.. (2025). Time-varying cost-effectiveness analysis of sodium-glucose cotransporter-2 inhibitors in Chinese patients with heart failure and reduced ejection fraction: A microsimulation of the real-world population. Frontiers in Pharmacology. 16. 1527972–1527972. 2 indexed citations

Mao, Yunhe, et al.. (2025). A leave-one-out algorithm for contribution analysis in component network meta-analysis. BMC Medical Research Methodology. 25(1). 191–191.

Shen, Yanjiao, Qingyang Shi, Xinyu Zou, et al.. (2024). Time‐dependent risk of fracture in adults with type 2 diabetes receiving anti‐diabetic drug: A one‐stage network meta‐analysis. Diabetes/Metabolism Research and Reviews. 40(2). e3780–e3780. 11 indexed citations

Shi, Qingyang, et al.. (2024). Real-World Data on Pathological Response and Survival Outcomes After Neoadjuvant Chemotherapy in HER2-Low Breast Cancer Patients. Clinical Breast Cancer. 24(5). 463–472.e2. 4 indexed citations

Zou, Xinyu, Qingyang Shi, Per Olav Vandvik, et al.. (2024). Sodium-glucose co-transporter-2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes: systematic review and meta-analysis. SHILAP Revista de lepidopterología. 3(1). e001009–e001009. 4 indexed citations

Shi, Qingyang, et al.. (2023). Maxillary Sinus Mucocele With Fungal Ball. Journal of Craniofacial Surgery. 34(8). e759–e760. 2 indexed citations

Shen, Yanjiao, Qingyang Shi, Kailei Nong, et al.. (2023). Exercise for sarcopenia in older people: A systematic review and network meta‐analysis. Journal of Cachexia Sarcopenia and Muscle. 14(3). 1199–1211. 211 indexed citations breakdown →

Liu, Dan, Nan Li, Yiling Zhou, et al.. (2023). Sex‐specific associations between skeletal muscle mass and incident diabetes: A population‐based cohort study. Diabetes Obesity and Metabolism. 26(3). 820–828. 18 indexed citations

Zhou, Yiling, Nan Li, Xiangyang Chen, et al.. (2022). Stress hyperglycemia ratio and in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes. Cardiovascular Diabetology. 21(1). 290–290. 51 indexed citations

10.

Zou, Xinyu, Qingyang Shi, Per Olav Vandvik, et al.. (2022). Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure. Annals of Internal Medicine. 175(6). 851–861. 34 indexed citations

11.

Du, Heyue, Qingyang Shi, Peige Song, et al.. (2022). Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019. Frontiers in Cardiovascular Medicine. 9. 903126–903126. 25 indexed citations

12.

Li, Ling, Jiali Liu, Xiujuan Li, et al.. (2021). The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 11 indexed citations

13.

Zheng, Hanrui, Min Liu, Sheyu Li, et al.. (2021). Sodium-Glucose Co-Transporter-2 Inhibitors in Non-Diabetic Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 12. 706914–706914. 39 indexed citations

14.

Zhang, Shengzhao, Ting Xu, Qingyang Shi, et al.. (2021). Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis. Frontiers in Medicine. 8. 698437–698437. 16 indexed citations

15.

Shi, Qingyang, et al.. (2021). Contaminants of emerging concerns in recycled water: Fate and risks in agroecosystems. The Science of The Total Environment. 814. 152527–152527. 56 indexed citations

16.

Zeng, Li, Ying Li, Yiling Zhou, et al.. (2021). Different Lipid Parameters in Predicting Clinical Outcomes in Chinese Statin-Naïve Patients After Coronary Stent Implantation. Frontiers in Cardiovascular Medicine. 8. 638663–638663. 5 indexed citations

17.

Müller, Mette H.B., Daniel Schlenk, Åse Krøkje, et al.. (2021). Effects of an environmentally relevant PFAS mixture on dopamine and steroid hormone levels in exposed mice. Toxicology and Applied Pharmacology. 428. 115670–115670. 48 indexed citations

18.

Wang, Yang, Song Liu, Qingyang Shi, et al.. (2021). Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review. Frontiers in Pharmacology. 12. 669814–669814. 26 indexed citations

19.

Shi, Qingyang, et al.. (2021). Fertility problems in males carrying an inversion of chromosome 10. Open Medicine. 16(1). 316–321. 9 indexed citations

20.

Zhou, Yiling, Miye Wang, Si Wang, et al.. (2021). Diabetes in Patients With Heart Failure With Reduced Ejection Fraction During Hospitalization: A Retrospective Observational Study. Frontiers in Endocrinology. 12. 727188–727188. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact